Xeris Biopharma Holdings, Inc. XERS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s operating lease ROU assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating lease ROU assets of $21.95M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating lease ROU assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating lease ROU assets decreased by 2.6% year-over-year, from $22.53M to $21.95M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.